**Core Concept**
Pulmonary vasoconstriction is a physiological response that helps regulate blood flow and pressure in the lungs. It involves the constriction of pulmonary arteries, which increases vascular resistance and helps to match blood flow with alveolar ventilation.

**Why the Correct Answer is Right**
The correct answer is due to the release of **endothelin-1 (ET-1)**, a potent vasoconstrictor peptide produced by endothelial cells. ET-1 binds to its receptor on smooth muscle cells, triggering a cascade of intracellular signaling events that ultimately lead to muscle contraction and pulmonary vasoconstriction. This response is also influenced by the **hypoxia-inducible factor (HIF)**, which is activated in response to low oxygen levels in the alveoli.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because **thromboxane A2 (TXA2)** is a vasoconstrictor, but it is primarily involved in platelet aggregation and is not the primary cause of pulmonary vasoconstriction.
* **Option B:** This option is incorrect because **nitric oxide (NO)** is a potent vasodilator, which would actually decrease pulmonary vascular resistance.
* **Option C:** This option is incorrect because **histamine** is a vasodilator in the lungs, but it can also cause bronchoconstriction and is not a primary cause of pulmonary vasoconstriction.

**Clinical Pearl / High-Yield Fact**
Pulmonary vasoconstriction is a key mechanism that helps to match blood flow with alveolar ventilation, and it is an important adaptive response to hypoxia and other respiratory insults.

**Correct Answer: D. Endothelin-1**